Cladribine and Lymph follicular hypertrophy - from FDA reports

Lymph follicular hypertrophy is found among people who take Cladribine, especially for people who are male, 60+ old , have been taking the drug for 1 - 6 months, also take medication Etoposide, and have Chronic lymphocytic leukaemia. This study is created by eHealthMe based on reports of 1,222 people who have side effects when taking Cladribine from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and find Care Guides (see testimonials).

On Sep, 24, 2018

1,222 people reported to have side effects when taking Cladribine.
Among them, 12 people (0.98%) have Lymph follicular hypertrophy

Number of reports submitted per year:

Could Cladribine cause Lymph follicular hypertrophy?

Time on Cladribine when people have Lymph follicular hypertrophy *:

Gender of people who have Lymph follicular hypertrophy when taking Cladribine *:

  • female: 41.67 %
  • male: 58.33 %

Age of people who have Lymph follicular hypertrophy when taking Cladribine *:

Top conditions involved for these people *:

  1. Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 3 people, 25.00%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 1 person, 8.33%
  3. Malignant Histiocytosis (cancerous increase in the number of immune cells): 1 person, 8.33%
  4. Lymphoma (cancer that begins in immune system cells): 1 person, 8.33%
  5. Langerhans' Cell Granulomatosis: 1 person, 8.33%

Click here to view more results or personalize the results to your gender and age

Top co-used drugs for these people *:

  1. Cytarabine: 4 people, 33.33%
  2. Etoposide: 4 people, 33.33%
  3. Zevalin: 3 people, 25.00%
  4. Vinblastine Sulfate: 3 people, 25.00%
  5. Cyclophosphamide: 3 people, 25.00%

Click here to view more results or personalize the results to your gender and age

Top other side effects for these people *:

  1. Fever: 6 people, 50.00%
  2. Interstitial Lung Disease: 4 people, 33.33%
  3. Hepatomegaly (abnormal enlargement of the liver): 3 people, 25.00%
  4. Sinusitis Fungal (fungal infection of sinus): 3 people, 25.00%
  5. Anaphylaxis (serious allergic reaction that is rapid in onset and may cause death): 3 people, 25.00%

Click here to view more results or personalize the results to your gender and age

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study

Are you new to Cladribine or have questions?

On eHealthMe, Care Guides are people who "have been there". Many of them have been living or working with a drug, a condition, or both for a long time and gained substantial experience. Follow a Care Guide below to get answers between doctor visits, and guidance in everyday life.

More Care Guides for: Cladribine, Lymph follicular hypertrophy

Volunteer or get paid to help people with your care experience

Do you have Lymph follicular hypertrophy while taking Cladribine?

Related studies


Cladribine has active ingredients of cladribine. (latest outcomes from Cladribine 1,226 users)

Lymph follicular hypertrophy

Lymph follicular hypertrophy (an increase in the size of the lymph node follicles) has been reported by people with rheumatoid arthritis, multiple sclerosis, high blood pressure, psoriasis, osteoporosis (latest reports from 28,547 Lymph follicular hypertrophy patients).

Drugs that are associated with Lymph follicular hypertrophy
Lymph follicular hypertrophy (1,923 drugs)
Could your condition cause Lymph follicular hypertrophy
Lymph follicular hypertrophy (1,674 conditions)
Cladribine side effects
Browse all side effects of Cladribine
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Cladribine and have Lymph follicular hypertrophy

Recent updates

General studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.